Nonsense. This was a science presentation, not an investor presentation and none of the “traders” you’re talking about were even watching. The audience was very limited and small. The entrance fee alone prohibited most but us same old shareholders from watching.
The fact is it was all about a pre-set attack. Adam started his efforts with the easily disproven allegations about IP. He switched to his old “the trial failed” nonsense because he had nowhere else to go. But the reality was, that was so flatly false it is and will become obvious over time, and then the nature of his article will be revealed to a much broader audience yet to understand what happened there.
But the trading was very limited to a set of people swing trading it with the help of a virtual pre-assembled army of market makers. Adam started the false allegations and rumors which he did not prove, on social media and then released his false report with the false blaring headline.
The reality is, even gullible traders likely saw an opportunity to make money at that point. But not long after all of that, the real story trickled out and the shares leveled. And the reality further was that there was no publication and the company was still subject to embargo, so the runup also, was premature.
The stock settled flat at that point, YTD. Quite telling. But Adam’s false narrative good days and weeks to trickle around and then get removed by various sites.
This is an obscure stock. Very few people know about it or DCVax-L. It’s quite easy for regulators to track who is trading it and what is going on. It’s not some massive market, it’s a very discrete and small set of players.
Market Data 
Markets 
AI
